THE BASIC PRINCIPLES OF SITUS JUDI MBL77

mutations presented the fact that, as spelled out below, CLL therapy relies to the existence or absence of these mutations. The present consensus is the fact, apart from clonal mutations, subclonal mutations by using a variant allelic frequency ranging from 5 to ten% (and thus under the brink of detection by typical molecular approaches) could also